|
|
||||||||
Papers In Press, published online ahead of print December 9, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UCDavis Med Ctr, Sacramento, CA 95817
Corresponding Author: ijialal{at}ucdavis.edu
C-reactive protein (CRP) is the prototypic marker of inflammation and a strong predictor of cardiovascular events in humans. There are questions as to the validity of the biological effects of CRP in spite of adhering to rigorous control measures minimizing endotoxin (LPS) contamination in these in vitro studies. In the present study, we addressed the key question of endotoxin contamination in CRP preparations using TLR4 knock down endothelial cells. Human aortic endothelial cells transfected with prevalidated TLR4 siRNA and scrambled siRNA controls were challenged with pleural fluid derived CRP or LPS for 12-16hrs. Secreted IL-6, IL-1b, IL-8, PAI-1 levels and eNOS activity were determined. TLR4 knock down in HAECs significantly decreased LPS induced IL-1b, IL-6, IL-8, while stimulatory effects of CRP were similar in both Sc control and TLR4 knock down cells. Furthermore, CRP significantly stimulated PAI-1 levels in both control and TLR4 transfected cells and inhibited eNOS activity, while LPS effects were negated in TLR4 transfected cells. Data presented cogently demonstrate and further confirm the biological effects of CRP on HAECs are independent of LPS and are thus due to native protein per se. This is the first study to positively implicate and authenticate the significance of earlier in vitro reports on CRP biological effects.
Revised on December 8, 2006
Accepted on December 9, 2006
Biological effects of C-reactive protein are not due to endotoxin contamination: Evidence from toll like receptor 4 knock-down human aortic endothelial cells
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. R. Dasu, S. Devaraj, L. Zhao, D. H. Hwang, and I. Jialal High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation Diabetes, November 1, 2008; 57(11): 3090 - 3098. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Devaraj, N. Torok, M. R. Dasu, D. Samols, and I. Jialal Adiponectin Decreases C-Reactive Protein Synthesis and Secretion From Endothelial Cells: Evidence for an Adipose Tissue-Vascular Loop Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1368 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Singh, M. R. Dasu, P. G. Yancey, A. Afify, S. Devaraj, and I. Jialal Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats J. Lipid Res., May 1, 2008; 49(5): 1015 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Singh, M. V. Suresh, D. C. Prayther, J. P. Moorman, A. E. Rusinol, and A. Agrawal C-Reactive Protein-Bound Enzymatically Modified Low-Density Lipoprotein Does Not Transform Macrophages into Foam Cells J. Immunol., March 15, 2008; 180(6): 4316 - 4322. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Van Vre, H. Bult, V. Y. Hoymans, V. F.I. Van Tendeloo, C. J. Vrints, and J. M. Bosmans Human C-Reactive Protein Activates Monocyte-Derived Dendritic Cells and Induces Dendritic Cell-Mediated T-Cell Activation Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 511 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Grad, M. Golomb, I. Mor-Yosef, N. Koroukhov, C. Lotan, E. R. Edelman, and H. D. Danenberg Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H489 - H495. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Szmitko and S. Verma C-Reactive Protein and Reendothelialization: NO Involvement Circ. Res., May 25, 2007; 100(10): 1405 - 1407. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |